Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
This study is testing a new device called the Half Moon Transcatheter Mitral Valve Repair (TMVr) System. This system is designed to fix a leaky mitral valve (mitral regurgitation) in your heart without open-heart surgery. It's for people aged 21 to 95 who have severe symptoms from their leaky valve and are considered too high-risk for traditional surgery. The main goal of this study is to see how safe the Half Moon TMVr System is. The study plans to enroll 30 participants, but its current recruitment status is unclear.
- Study design
- This is an Early Feasibility Study (EFS) that will enroll 30 participants. It is a single-arm study, meaning all participants will receive the Half Moon TMVr System.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for adverse events for at least 30 days after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
At a glance
Conditions
Where it's being run
5 sites across 4 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Adverse Events30 Days
Evaluation of the nature, severity and frequency of complications associated with the delivery and/or implantation of the device